LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption
Nature Medicine2016Vol. 22(5), pp. 539–546
Citations Over TimeTop 1% of 2016 papers
Jian Luo, Zhengfeng Yang, Yu Ma, Zhiying Yue, Hongyu Lin, Guojun Qu, Jingping Huang, Wentao Dai, Chenghai Li, Chunbing Zheng, Leqin Xu, Huaqing Chen, Jiqiu Wang, Dali Li, Stefan Siwko, Josef Penninger, Guang Ning, Jianru Xiao, Mingyao Liu
Related Papers
- → Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (Review)(2014)205 cited
- Rank/Rankl/opg: literature review.(2012)
- → Expression Profiles of Receptor Activator of Nuclear Factor κB Ligand, Receptor Activator of Nuclear Factor κB, and Osteoprotegerin Messenger RNA in Aged and Ovariectomized Rat Bones(2001)106 cited
- → Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis(2013)38 cited
- Effects of osteoprotegerin, RANK and RANKL on bone destruction and collapse in avascular necrosis femoral head.(2016)